Management of Severe and Moderate Hypercholesterolemia in Young Women and Men.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34780599.
- Also identified by DOI 10.1001/jamacardio.2021.4983 and PMC identifier 8593830.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses clinical registry data to assess achievement of low-density lipoprotein cholesterol reduction and lipid-lowering therapy prescribing patterns among adults aged 20 to 39 years with moderate to severe hypercholesterolemia.
Medical subject headings
- Anticholesteremic Agents
- Ezetimibe
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypercholesterolemia
- PCSK9 Inhibitors
- Practice Patterns, Physicians'